Discovery of a potential hematologic malignancies therapy: Selective and potent HDAC7 PROTAC degrader targeting non-enzymatic function
Yuheng Jin(Zhejiang University), Xiaowu Dong(Second Affiliated Hospital of Zhejiang University)
Cited by 8
Related Papers
ADCdb: the database of antibody–drug conjugates
|Nucleic Acids Research|2023|69
TransFoxMol: predicting molecular property with focused attention
|Briefings in Bioinformatics|2023|40
Rational Identification of Novel Antibody‐Drug Conjugate with High Bystander Killing Effect against Heterogeneous Tumors
|Advanced Science|2024|34
Discovery of a Highly Potent and Selective BRD9 PROTAC Degrader Based on E3 Binder Investigation for the Treatment of Hematological Tumors
|Journal of Medicinal Chemistry|2024|19
Discovery of New Phenyltetrazolium Derivatives as Ferroptosis Inhibitors for Treating Ischemic Stroke: An Example Development from Free Radical Scavengers
|Journal of Medicinal Chemistry|2024|17